BIOAVAILABILITY AND PHARMACOKINETIC ANALYSIS OF DRUG RESPONDING SYSTEMS.SMOLEN VF.1978; ANNU. REV. PHARMACOL. TOXICOL.; U.S.A.; DA. 1978; VOL. 18; PP. 495-522; BIBL. 5 P.Article

DRUG ABSORPTION ANALYSIS FROM PHARMACOLOGICAL DATA. III. INFLUENCE OF POLYMERS AND PH ON TRANSCORNEAL BIOPHASIC AVAILABILITY AND MYDRIATIC RESPONSE OF TROPICAMIDE = L'ANALYSE DE L'ABSORPTION DES MEDICAMENTS D'APRES LES DONNEES PHARMACOLOGIQUES. III. INFLUENCE DES POLYMERES ET DU PH SUR LA DISPONIBILITE BIPHASIQUE TRANSCORNEENNE ET LA REPONSE MYDRIATIQUE DE LA TROPICAMIDESMOLEN VF; SCHOENWALD RD.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 10; PP. 1582-1585; BIBL. 24REF.Article

BIOAVAILABILITY ANALYSIS OF CHLORPROMAZINE IN HUMANS FROM PUPILOMETRIC DATA. = ANALYSE DE LA BIODISPONIBILITE DE LA CHLORPROMAZINE CHEZ L'HOMME D'APRES LES DONNEES PUPILLOMETRIQUESSMOLEN VF; MURDOCK HR JR; WILLIAMS EJ et al.1975; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1975; VOL. 195; NO 3; PP. 404-415; BIBL. 1 P.Article

DRUG INPUT OPTIMIZATION: BIOAVAILABILITY-EFFECTED TIME-OPTIMAL CONTROL OF MULTIPLE, SIMULTANEOUS, PHARMACOLOGICAL EFFECTS AND THEIR INTERRELATIONSHIPS = L'OPTIMISATION DE L'ABSORPTION DES MEDICAMENTS: CONTROLE OPTIMAL DANS LE TEMPS, EFFECTUE PAR LA BIODISPONIBILITE, DES EFFETS PHARMACOLOGIQUES MULTIPLES SIMULTANES ET DE LEURS INTERRELATIONSSMOLEN VF; TURRIE BD; WEIGAND WA et al.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 12; PP. 1941-1952; BIBL. 33 REF.Serial Issue

OXYGEN PERMEABILITY COEFFICIENTS OF POLYMERS FOR HARD AND SOFT CONTACT LENS APPLICATIONSWU HUANG YANG; SMOLEN VF; PEPPAS NA et al.1981; J. MEMBR. SCI.; ISSN 0376-7388; NLD; DA. 1981; VOL. 9; NO 1-2; PP. 53-67; BIBL. 33 REF.Article

BIOAVAILABILITY AND PHARMACOKINETIC ANALYSIS OF CHLORPROMAZINE IN HUMAN AND ANIMALS USING PHARMACOLOGICAL DATASMOLEN VF; WILLIAMS EJ; KUEHN PB et al.1975; CANADA J. PHARM. SCI.; CANADA; DA. 1975; VOL. 10; NO 4; PP. 95-106; ABS. FR.; BIBL. 40 REF.Article

PHARMACOKINETICS OF CHLORPROMAZINE INDUCED MIOTIC RESPONSE IN RABBITS.KUEHN PB; JHAWAR AK; WEIGAND WA et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 11; PP. 1593-1599; BIBL. 23 REF.Article

PHARMACOLOGICAL RESPONSE DATA FOR COMPARATIVE BIOAVAILABILITY STUDIES OF CHLORPROMAZINE ORAL DOSAGE FORMS IN HUMANS. I. PUPILOMETRY.SMOLEN VF; MURDOCK HR JR; STOLTMAN WP et al.1975; J. CLIN. PHARMACOL.; U.S.A.; DA. 1975; VOL. 15; NO 11-12; PP. 734-751; BIBL. 26 REF.Article